Parmax Pharma Limited Share Price

Parmax Pharma Ltd is an India-based company, which is engaged in active pharmaceutical ingredients (API) and contract manufacturing operations (CMO) business. It uses quality by design techniques to produce complex molecules enabling customers to create formulations. The Company’s manufacturing units run in accordance with current good manufacturing practices (cGMP). Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Ormeloxifene Hydrochloride I.P., Milnacipram HCl, Calciumpoly Carbophil usp, Levosulpride, Paliperidone, Edaravone, Lacosamide, Iloperidone, Prasugrel HCl, 2-Acetyl Thiophene, Morpholine Hydrochloride, Camphor Sulfonyl Chloride, ISB-I (2-Chlorobenzaldehyde-5-Sulfonic acid disodium salt), Benzaldehyde-2, 5-Di-Sulfonic acid disodium salt, 2-picolinoxylidide, 4-Octyl amino pyridine (4-OAP), Sitagliptin phosphate Monohydrate API, Solifenacin Succinate API, Vilazodone Hydrochloride API, and Azelnidipine API.As of 25 May 2026, Parmax Pharma Limited share price is ₹37.00. The stock opened at ₹36.06, compared to its previous close of ₹36.24. During today's trading session, Parmax Pharma Limited share price moved in the range of ₹33.16 to ₹38.85, with an average price of ₹36.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.16 and a high of ₹38.85.

The market capitalization of Parmax Pharma Limited is ₹14 Crs, with a P/E ratio of -2.7 and a dividend yield of 0.00%.